thiazoles has been researched along with Peripheral Nerve Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Motta, KP; Domingues, NLC; Luchese, C; Santos, BF; Wilhelm, EA | 1 |
| Bentley, J; Berthemy, A; Bosanac, T; Boyce, S; Brearley, A; Danker, K; Devraj, R; Engber, T; Hermann, M; Hughes, RO; Kopatz, J; Krauss, R; Young, K | 1 |
| Yu, J; Zhang, J; Zhao, H | 1 |
| Chu, KL; Dart, MJ; McGaraughty, S; Meyer, MD; Yao, BB | 1 |
| Atweh, SF; Bach, JF; Dardenne, M; Jabbur, SJ; Saadé, NE; Safieth-Garabedian, B | 1 |
| Hanaoka, K; Sawamura, S; Sekiyama, H; Takeda, K; Tamai, H | 1 |
| Anderson, S; Illanes, O; Jessen, BA; Niesman, M; Zwick, L | 1 |
| Dudhgaonkar, SP; Kumar, D; Naik, AK; Raviprakash, V; Tandan, SK | 1 |
| Ondo, W; Tan, EK | 1 |
| Kondo, M; Nakano, K; Nishioka, H; Terashima, H; Yoshida, T; Yoshioka, K | 1 |
10 other study(ies) available for thiazoles and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Target enzymes in oxaliplatin-induced peripheral neuropathy in Swiss mice: A new acetylcholinesterase inhibitor as therapeutic strategy.
Topics: Adenosine Triphosphatases; Analgesics; Animals; Anxiety; Benzoates; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Cognitive Dysfunction; Disease Models, Animal; Female; Hippocampus; Indoles; Male; Mice; Oxaliplatin; Oxidative Stress; Peripheral Nervous System Diseases; Spinal Cord; Thiadiazoles; Thiazoles | 2022 |
Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Armadillo Domain Proteins; Axons; Cells, Cultured; Cytoskeletal Proteins; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Induced Pluripotent Stem Cells; Mice; Mice, Knockout; Paclitaxel; Peripheral Nervous System Diseases; Thiazoles | 2021 |
HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy.
Topics: Blood Glucose; Cell Line; Cell Survival; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; HMGB1 Protein; Humans; Inflammation; NF-kappa B p50 Subunit; Peripheral Nervous System Diseases; Real-Time Polymerase Chain Reaction; Retinal Ganglion Cells; RNA, Messenger; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Toll-Like Receptor 4; Transfection; Up-Regulation | 2015 |
A CB(2) receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: contributions of spinal and peripheral CB(2) receptors.
Topics: Action Potentials; Animals; Camphanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Ganglia, Spinal; Male; Neurons; Peripheral Nervous System Diseases; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Rimonabant; Spinal Cord; Thiazoles | 2009 |
A thymulin analogue peptide with powerful inhibitory effects on pain of neurogenic origin.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hot Temperature; Hyperalgesia; Ligation; Male; Meloxicam; Morphine; Pain; Pain Threshold; Peptides; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Reaction Time; Thiazines; Thiazoles; Thymic Factor, Circulating; Time Factors | 2003 |
Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation.
Topics: Animals; Cyclooxygenase 2; Male; Meloxicam; Neuroglia; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Spinal Cord; Thiazines; Thiazoles | 2005 |
Retinal and peripheral nerve toxicity induced by the administration of a pan-cyclin dependent kinase (cdk) inhibitor in mice.
Topics: Animals; Apoptosis; Benzamides; Cyclin-Dependent Kinases; Enzyme Inhibitors; Female; In Situ Nick-End Labeling; Male; Mice; Nerve Degeneration; Peripheral Nervous System; Peripheral Nervous System Diseases; Retina; Retinal Diseases; Sciatic Nerve; Thiazoles | 2006 |
Ameliorative effect of combined administration of inducible nitric oxide synthase inhibitor with cyclooxygenase-2 inhibitors in neuropathic pain in rats.
Topics: Animals; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Guanidines; Hyperalgesia; Lactones; Male; Meloxicam; Neuralgia; Neurons, Afferent; Nitric Oxide; Nitric Oxide Synthase Type II; Nociceptors; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Reaction Time; Sciatic Neuropathy; Sulfones; Thiazines; Thiazoles; Treatment Outcome | 2007 |
Clinical characteristics of pramipexole-induced peripheral edema.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Edema; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Peripheral Nervous System Diseases; Pramipexole; Retrospective Studies; Severity of Illness Index; Thiazoles | 2000 |
Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
Topics: Aldehyde Reductase; alpha-Methyltyrosine; Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Erythrocytes; Female; Methyltyrosines; Neural Conduction; Norepinephrine; Peripheral Nervous System Diseases; Rats; Rats, Inbred Strains; Rhodanine; Sciatic Nerve; Sorbitol; Streptozocin; Sugar Alcohol Dehydrogenases; Sympathetic Nervous System; Thiazoles; Thiazolidines; Triiodothyronine | 1987 |